全文获取类型
收费全文 | 125篇 |
免费 | 5篇 |
国内免费 | 6篇 |
专业分类
儿科学 | 6篇 |
妇产科学 | 2篇 |
基础医学 | 15篇 |
口腔科学 | 4篇 |
临床医学 | 19篇 |
内科学 | 26篇 |
神经病学 | 3篇 |
特种医学 | 35篇 |
外科学 | 5篇 |
综合类 | 5篇 |
预防医学 | 4篇 |
药学 | 9篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2020年 | 1篇 |
2018年 | 2篇 |
2015年 | 4篇 |
2014年 | 1篇 |
2013年 | 4篇 |
2012年 | 2篇 |
2011年 | 1篇 |
2010年 | 4篇 |
2009年 | 4篇 |
2008年 | 4篇 |
2007年 | 2篇 |
2006年 | 1篇 |
2005年 | 4篇 |
2004年 | 2篇 |
2003年 | 1篇 |
2001年 | 2篇 |
1999年 | 1篇 |
1998年 | 12篇 |
1997年 | 8篇 |
1996年 | 14篇 |
1995年 | 7篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 2篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 6篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有136条查询结果,搜索用时 15 毫秒
81.
Background
Otitis media (OM) is a major health problem in both developed and developing countries.Objective
To determine the pattern of bacterial isolates in patients with chronic suppurative otitis media(CSOM) in Ilorin, Nigeria.Methods
A prospective study carried out in University of Ilorin Teaching Hospital, Nigeria among consenting patients with CSOM attending the ENT clinic over a period of 7months. Informed consent was obtained from the patients or caregivers and approval for the study obtained from ethical committee. Structured questionnaire was administered and microbiological analysis done, data obtained was entered into SPSS statistical software and results presented in tables and figures.Results
A total of 134 patients aged 5–64yrs with chronic suppurative otitis media were interviewed with a mean age of 17.0 (S.D. =15.1±1.30). About 55.2% of the respondents were under 10yrs. Seventy-two (53.7%) of the respondents were males with M:F=1.2:1. The gram stain showed predominantly gram negative organisms (71.6%). Pseudomonas aeruginosa was the commonest middle ear pathogenic organism identified and the sensitivity pattern highly favoured ciprofloxacinConclusion
CSOM is still a childhood problem among the under tens'' more prevalent among males and the commonest agent is Pseudomonas aeruginosa. Ciprofloxacin is still the most sensitive antibiotics in vitro. 相似文献82.
CA Pappa MG Alexandrakis A Boula FE Psarakis A Kolovou V Bantouna E Stavroulaki G Tsirakis 《Hematological oncology》2013,31(4):201-205
Angiogenesis is an essential process for the expansion of multiple myeloma (MM), in which many angiogenic factors participate. Endoglin (CD105) is a transforming growth factor‐β co‐receptor, being mainly expressed in angiogenic endothelial cells and has been used as a marker of tumor angiogenesis, having prognostic potential. The aim of the study was to evaluate serum levels of soluble CD105 (sCD105) in MM patients, both during diagnosis and after effective conventional chemotherapy, in the plateau phase, and to correlate them with the clinical stage of the disease, as well as with the known angiogenic factors vascular endothelial growth factor, angiogenin and interleukin‐18 (IL‐18). Serum levels of the aforementioned factors were measured, by enzyme‐linked immunosorbent assay, in 56 newly diagnosed MM patients, in 35 of them who entered plateau phase and in 24 healthy controls. Bone marrow aspirations were also performed in all patients to determine plasma cell infiltration. All measured cytokines were higher in MM patients compared with controls and with advancing disease stage (p < 0.001 for all cases). Furthermore, the values of all factors decreased significantly in the plateau phase (p < 0.001 for all cases). Serum levels of sCD105 correlated with the other angiogenic cytokines, whereas only serum levels of angiogenin had prognostic value for the survival. In conclusion, CD105 and the angiogenic cytokines vascular endothelial growth factor, angiogenin and IL‐18, seem to have emerging roles both in angiogenesis and tumor growth in MM. Copyright © 2013 John Wiley & Sons, Ltd. 相似文献
83.
Pulmonary embolism: validation of spiral CT angiography in 149 patients 总被引:41,自引:1,他引:40
van Rossum AB; Pattynama PM; Ton ER; Treurniet FE; Arndt JW; van Eck B; Kieft GJ 《Radiology》1996,201(2):467
84.
The prevalence and mode of spread of gonococcal infections was studied among prepubertal children in Nigeria. Of 16 children with symptoms suggestive of sexually transmissible diseases (STD), 9 (56%) had gonorrhoea, while no causative organism was found in 7. The majority (7; 78%) of the gonococcal isolates produced penicillinase. Three of the cases were by child-to-child transmission, with female peers as the initiators. Prepubertal children should no longer be ignored as propagators of STD. 相似文献
85.
86.
目的:观察小檗碱对转基因小鼠胰岛β细胞株胰岛素受体和胰岛素样生长因子1受体mRNA表达的影响。方法:实验于2005-09/2006-10在华中科技大学同济医学院附属同济医院中西医结合研究所完成。①实验材料:培养NIT-1细胞,在低糖(5.5mmol/L)和高糖(11.1mmol/L)环境下,分别加入0,1,3,10,30μmol/L的小檗碱和1μmol/L的格列苯脲,0μmol/L小檗碱组为空白对照组。②实验评估:培养24h后,采用四甲基偶氮唑盐法检测小檗碱NIT-1细胞增殖抑制作用;逆转录-聚合酶链反应测定NIT-1细胞胰岛素受体和胰岛素样生长因子1受体mRNA表达。结果:①四甲基偶氮唑盐法检测发现,不同浓度小檗碱(1~30μmol/L)与NIT-1细胞作用24h后,小檗碱组吸光度值比空白对照组低,随着小檗碱浓度的增加,吸光度值逐渐从0.356±0.061降低至0.162±0.014,而且在各组之间有显著性差异。②在低糖及高糖环境下,与空白对照组相比,小檗碱能促进NIT-1细胞胰岛素受体mRNA的表达(低糖环境:0.27±0.04,0.49±0.02;高糖环境:0.22±0.04,0.42±0.03;P<0.01),但仍低于格列苯脲组(低糖环境:0.75±0.22;高糖环境:0.78±0.01;P<0.01);而且随着小檗碱浓度的升高,NIT-1细胞胰岛素受体mRNA表达的增加更为明显,分别从0.49±0.02增高至0.68±0.44及从0.42±0.03增高至0.71±0.01。与空白对照组相比,小檗碱组胰岛素样生长因子1受体mRNA的表达无明显改变。结论:小檗碱促进胰岛素分泌,其作用机制可能与促进胰岛β细胞胰岛素受体mRNA表达有关。 相似文献
87.
A Shapiro ; T Abe ; LM Aledort ; K Anderle ; MW Hilgartner ; M Kunschak ; FE Preston ; GE Rivard ; K Schimpf 《Transfusion》1995,35(3):204-208
BACKGROUND: Vapor-heated human factor VII concentrate and human factor IX complex are both obtained from prothrombin complex, undergo similar methods of manufacture, and are subjected to an identical two-step vapor-heating process for virus inactivation. STUDY DESIGN AND METHODS: Intermediate-purity vapor-heated human factor VII concentrate and vapor- heated human factor IX complex were monitored for safety with regard to viral infection in the context of an International Factor Safety Study, a prospective study that follows the revised recommendations from the International Congress of Thrombosis and Hemostasis (ICTH). Because the rarity of the respective hereditary deficiencies would have made separate analyses unrealizable, the results were combined for the final analysis. Entry required that patients have no history of transfusion with any blood derivative. After the first infusion of the study drug, patients were monitored for 6 months for the development of non-A, non- B hepatitis (NANBH) and infection with hepatitis B virus (HBV) and for 15 months for infection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV). An event was defined as a positive result on any test for any infection. An alanine aminotransferase level more than 2.5 times the upper limit of normal on two consecutive occasions was defined as an event for NANBH. HBV infection was monitored with tests for three different HBV markers: the HBV surface antigen, antibody against the HBV surface antigen, and antibody against HBV core antigen. HCV and HIV infection were monitored with tests for HCV and HIV antibodies. RESULTS: The 25 patients who completed the study (1 has not completed the study and 1 dropped out) received a total of 434 infusions comprising 17 different production lots of the concentrates. Twenty patients were analyzable for NANBH and 25 for HCV and HIV infection. Since most patients had been given HBV vaccination, only 4 patients were analyzable for this end point. None of the patients showed evidence of having developed an event. These data satisfy ICTH criteria when the products are considered together, but vapor-heated factor VII concentrate does not qualify alone because there were only five patients in this group. CONCLUSION: Vapor-heated factor VII concentrate and vapor-heated factor IX complex are associated with a low risk of viral infection. Preliminary results are also presented, indicating that the concentrates are safe with regard to inhibitor development. 相似文献
88.
89.
Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients
The polymerase chain reaction (PCR) was used to detect hepatitis C (HCV) viral sequences (HCV-RNA) in clotting factor concentrates that had been stored at 4 degrees C for 1 to 16 years. A total of 43 concentrates were tested, comprising 31 batches of factor VIII, 6 of factor IX, 2 of antithrombin III, 3 of FEIBA, and 1 of factor VII. HCV- RNA was detected in 13 of the 43 batches (30.2%). Concentrates that had not undergone viral inactivation during manufacture were significantly more likely to contain detectable HCV-RNA than concentrates that had been virally inactivated (56.3% v 14.5%, P = .006). HCV sequences were more commonly detected in concentrates made from paid donor plasma than in those made from volunteer donor plasma (44% v 11%, P = .041), and more commonly in virally inactivated concentrates with pre-1989 than with post-1989 expiration dates (50% v 0%, P = .004). Of the four batches of heat-treated products that were HCV-RNA positive, at least three transmitted non-A, non-B hepatitis (NANBH). An association between the presence of HCV-RNA in concentrates and the development of NANBH was demonstrated in nine previously untreated patients on prospective follow-up. HCV-RNA was detected in the concentrates administered to the six patients whose alanine aminotransferase (ALT) abnormalities met the diagnostic criteria for NANBH and who later seroconverted for HCV, but it was not detected in the concentrates administered to the three patients whose ALT abnormalities failed to satisfy the diagnostic criteria and who did not seroconvert. We suggest that the use of this PCR technique to monitor clotting factor concentrates derived from pooled blood may potentially contribute to product safety. 相似文献
90.
Gratama JW; Naipal A; Oljans P; Zwaan FE; Verdonck LF; de Witte T; Vossen JM; Bolhuis RL; de Gast GC; Jansen J 《Blood》1984,63(6):1416-1423
Acute graft-versus-host disease (GVHD), a major complication of allogeneic bone marrow transplantation (BMT), is probably mediated by T lymphocytes present in the marrow graft. In this study, the repopulation of the peripheral blood with T4+ and T8+ T cells was investigated during the period preceding the occurrence of acute GVHD. Twenty-four allogeneic and 11 autologous BMT recipients were monitored from day 4 post-BMT onward by the use of monoclonal antibodies, indirect immunofluorescence, and flow cytometry. The recipients of allogeneic transplants received methotrexate as GVHD prophylaxis. Similar recovery patterns for T4+ and T8+ T cells were found following autologous and allogeneic BMT. However, lymphoid repopulation occurred at a clearly faster rate after autologous BMT. T4+ T cells were the first to reappear in the peripheral blood, followed by T8+ T cells 4-7 days later. The T8+ T cell reconstitution occurred at an even faster rate in patients who were to develop grade II-IV GVHD, as compared with those with grade O-I GVHD, thus leading to an earlier decrease in the T4/T8 ratio. Of 10 patients with a T4/T8 ratio less than 2.5 at day 19, 9 developed grade II-IV GVHD and 1 showed no GVHD. Of 14 patients with a ratio greater than 2.5 at that time, only 2 developed grade II-IV and 12 grade O-I GVHD (p less than 0.001). In the 11 patients developing grade II-IV GVHD, the T4/T8 ratio decreased to values less than 2.5 before the first clinical symptoms of GVHD in 9; it coincided in one and occurred later in another patient. Thus, early monitoring of the T4/T8 ratio can distinguish patients at risk of developing grade II-IV GVHD. 相似文献